Bitnomial launches Injective futures in the United States, which is expected to support the eligibility for spot ETF applications

According to Cointelegraph, Chicago-based cryptocurrency derivatives exchange Bitnomial has launched Injective monthly futures contracts, marking the first entry of the Injective token into the regulated derivatives market in the United States. The contract is settled in INJ, expires monthly, and allows traders to gain price exposure without holding the underlying asset, with all cryptocurrencies or USD available as collateral through Bitnomial.

Institutional clients can trade the futures immediately, while retail trading is expected to open in the coming weeks through Bitnomial's Botanical platform. Bitnomial also plans to introduce INJ perpetual futures and options.

Analysts state that the launch of the Injective futures contracts will begin a six-month trading record, which is expected to support the application for a spot ETF. Previously, Canary Capital submitted a staking-based INJ ETF application to the SEC.

This content is provided for general informational purposes only and doesn't constitute financial, investment, legal, or tax advice. Any events, rewards, online promotions, or related information mentioned herein should not be considered a recommendation, solicitation, or invitation to purchase, sell, trade, or otherwise deal in any crypto assets. Crypto assets are highly volatile and may result in loss. The availability of WEEX services, products, and related events may vary by region. You are responsible for ensuring that your participation is in accordance with applicable local laws and regulations.